Table 7.
Effect of dietary supplementation of mannan oligosaccharide to sow or piglet on secretory immunoglobulin A (sIgA) in piglet jejunum mucosa (mean ± SD)1
Dietary treatment2 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Sow diets | Piglet diets | Piglet treatments | P-value3 | ||||||||
Item4 | sCON | sMOS | pCON | pMOS | sCON-pCON | sCON-pMOS | sMOS-pCON | sMOS-pMOS | S | P | S×P |
No. | 12 | 12 | 12 | 12 | 6 | 6 | 6 | 6 | |||
sIgA, mg/g pro. | 4.97 ± 0.74a | 6.87 ± 1.12b | 5.61 ± 1.44 | 6.16 ± 1.23 | 4.48 ± 0.50 | 5.56 ± 0.52 | 6.98 ± 0.76 | 6.77 ± 1.49 | 0.04 | 0.61 | 0.45 |
1Sows were fed mannan oligosaccharide (MOS, Actigen, Alltech, Inc., Nicholasville, KY) from the 86th day of gestation until the end of lactation (d 20 post-farrowing), and piglets were fed it from day 7 to day 35 of age.
2Dietary treatments: sCON = sows fed control diet; sMOS = sows fed diet supplementation with 400 mg kg−1 MOS; pCON = piglets fed control diet; pMOS = piglets fed diet supplementation with 800 mg kg−1 MOS; sCON-pCON = sows fed control diet and piglets fed control diet; sCON-pMOS = sows fed control diet and piglets fed diet supplementation with 800 mg kg−1 MOS; sMOS-pCON = sows fed diet supplementation with 400 mg kg−1 MOS and piglets fed control diet; sMOS-pMOS = sows fed diet supplementation with 400 mg kg−1 MOS and piglets fed diet supplementation with 800 mg kg−1 MOS.
3S, sow dietary treatment; P, piglet dietary treatment; and S×P, the interaction effect of the sow and piglet dietary treatments.
4No., number of piglets; sIgA, mg/g pro., secretory immunoglobulin A concentration (mg/g protein) in piglet jejunum mucosa on day 35 of age.
a,bMeans in the same row with different superscripts differ (P < 0.05) between the same dietary treatment.